Cinclus Pharma Is A Clinical Stage Pharmaceutical Company Based In Stockholmswedenfounded In 2014The Company Specializes In Developing Small Molecule Therapies For Gastric Acid Related Diseasesparticularly Focusing On Gastroesophageal Reflux Diseasegerdandhelicobacter Pyloriinfectionswith A Team Of 18 Employeescinclus Pharma Operates In The Specialty Drug Manufacturing Sector And Is Listed On Nasdaq Stockholm Under The Ticker Cinpha The Lead Drug Candidatelinaprazan Glurateis A Potassium Competitive Acid Blocker Designed To Target Severe Gerd And Improve Treatment Efficacy Forhpyloriinfectionsthe Company Is Advancing This Candidate Through Clinical Trialsbuilding On Prior Studies Conducted By Its Founders At Astrazenecacinclus Pharma Aims To Redefine Gerd Treatment By Providing Faster Acting And Longer Lasting Therapieswhile Also Addressing Antibiotic Resistance Associated Withhpyloritreatment
